The massive authorized share increase (to 2B) combined with a distressed reverse split suggests the company may be positioning for future equity raises. Monitor for any subsequent shelf registration or offering announcements. The written consent provision could also facilitate a rapid activist or management-led action.
Price Chart
Executive Summary
Healthy Choice Wellness Corp. filed a Certificate of Amendment effecting a 1-for-35 reverse stock split, increasing authorized shares from 600M to 2B, and adding stockholder written consent rights. The reverse split (effective Aug 28, 2026) is likely a NYSE American minimum-bid-price compliance move, while the 3.33x authorized share increase signals potential future dilution. The written consent provision enables faster stockholder action, which could be used by either management or activists.
Key Facts
- 1-for-35 reverse stock split of Class A common stock effective 11:59 p.m. ET on August 28, 2026; no fractional shares issued (rounded up).
- Authorized capital stock increased from 600M to 2B shares (1.96B common, 40M preferred).
- Stockholders granted right to act by written consent in lieu of a meeting under Delaware law.
- Common stock began trading split-adjusted under new CUSIP 42227T303 on NYSE American at market open August 31, 2026.
Financial Impact
No immediate financial impact; authorized share count increased 3.33x from 600M to 2B shares, enabling future dilutive issuances. Reverse split reduces share count by 97% but does not change equity value.
Risk Factors
- Potential dilution from future equity offerings enabled by the increased authorized share count.
- Reverse split may not be sufficient to maintain NYSE American listing if the post-split price fails to stay above $1.
- Written consent provision could be used to push through actions without a stockholder meeting, reducing minority protections.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-040875 |
| Exhibit: ex3-1.htm | 0001493152-26-040875 |
| Document: 0001493152-26-040875-index-headers.html | 0001493152-26-040875 |
| Document: 0001493152-26-040875-index.html | 0001493152-26-040875 |
| Document: 0001493152-26-040875.txt | 0001493152-26-040875 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 19d ago | 8-K | $3.20 | awaiting T+20 | — | $2.41 (−24.69%) |
Sep 21, 2026 5w ago | 424B5 | $8.00 $1.92 | ▲ +76.00% | ▲ +75.09% | $2.41 (+69.87%) |
Sep 17, 2026 5w ago | Press Release | $8.09 $1.90 | ▲ +76.51% | ▲ +76.72% | $2.41 (+70.21%) |
Sep 17, 2026 5w ago | 424B5 | $8.09 $1.90 | ▲ +76.51% | ▲ +76.72% | $2.41 (+70.21%) |
Sep 17, 2026 5w ago | Press Release | $8.09 $1.90 | ▲ +76.51% | ▲ +76.72% | $2.41 (+70.21%) |
Aug 31, 2026 8w ago | 8-K | $7.44 | awaiting T+20 | — | $2.41 (+67.61%) |
Aug 26, 2026 8w ago | 8-K | $0.2585 | awaiting T+20 | — | $2.41 (−832.30%) |
Aug 26, 2026 8w ago | 424B5 | $0.2585 | awaiting T+20 | — | $2.41 (−832.30%) |
Aug 18, 2026 9w ago | 10-Q/A | $0.2650 $0.4043 | ▼ −52.56% | ▼ −54.31% | $2.41 (−809.43%) |
Aug 13, 2026 10w ago | DEFA14A | $0.2684 $0.2823 | ▲ +5.17% | ▲ +6.92% | $2.41 (+797.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers